Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne E Rosser

Showing results (71-80 of 95) with videos related to

Pageof 10
Sort By:
BMJ Open|August 1, 2024
Protocol for a randomised controlled unblinded feasibility trial of HD-DRUM: a rhythmic movement training application for cognitive and motor symptoms in people with Huntington's diseaseVasileios Ioakeimidis, Monica Busse, Cheney J G Drew, et al.
Cell Transplantation|January 5, 2016
Direct Comparison of Rat- and Human-Derived Ganglionic Eminence Tissue Grafts on Motor FunctionMariah J Lelos, Victoria H Roberton, Ngoc-Nga Vinh, et al.
Biomaterials Science|September 15, 2020
Heparin-based, injectable microcarriers for controlled delivery of interleukin-13 to the brainLucas Schirmer, Chloé Hoornaert, Debbie Le Blon, et al.
Human Brain Mapping|April 9, 2022
Mutation-related magnetization-transfer, not axon density, drives white matter differences in premanifest Huntington disease: Evidence from in vivo ultra-strong gradient MRIChiara Casella, Maxime Chamberland, Pedro L Laguna, et al.
Pilot and Feasibility Studies|February 16, 2018
Exploring computerised cognitive training as a therapeutic intervention for people with Huntington's disease (CogTrainHD): protocol for a randomised feasibility studyEmma Yhnell, Hannah Furby, Rachel S Breen, et al.
Brain : a Journal of Neurology|April 12, 2003
Progressive striatal and cortical dopamine receptor dysfunction in Huntington's disease: a PET studyNicola Pavese, Thomasin C Andrews, David J Brooks, et al.
Pilot and Feasibility Studies|June 25, 2020
A randomised feasibility study of computerised cognitive training as a therapeutic intervention for people with Huntington's disease (CogTrainHD)Emma Yhnell, Hannah Furby, Rachel S Lowe, et al.
Scientific Reports|September 2, 2016
Longitudinal in vivo MRI in a Huntington's disease mouse model: Global atrophy in the absence of white matter microstructural damageJessica J Steventon, Rebecca C Trueman, Da Ma, et al.
Neurology|March 26, 2021
Timing and Impact of Psychiatric, Cognitive, and Motor Abnormalities in Huntington DiseaseBranduff McAllister, James F Gusella, G Bernhard Landwehrmeyer, et al.
Cytotherapy|November 28, 2020
Induced pluripotent stem cells derived from the developing striatum as a potential donor source for cell replacement therapy for Huntington diseaseNarawadee Choompoo, Oliver J M Bartley, Sophie V Precious, et al.
Pageof 10

Showing results (71-80 of 95) with videos related to

Sort By:
Pageof 10
BMJ Open|August 1, 2024
Protocol for a randomised controlled unblinded feasibility trial of HD-DRUM: a rhythmic movement training application for cognitive and motor symptoms in people with Huntington's diseaseVasileios Ioakeimidis, Monica Busse, Cheney J G Drew, et al.
Cell Transplantation|January 5, 2016
Direct Comparison of Rat- and Human-Derived Ganglionic Eminence Tissue Grafts on Motor FunctionMariah J Lelos, Victoria H Roberton, Ngoc-Nga Vinh, et al.
Biomaterials Science|September 15, 2020
Heparin-based, injectable microcarriers for controlled delivery of interleukin-13 to the brainLucas Schirmer, Chloé Hoornaert, Debbie Le Blon, et al.
Human Brain Mapping|April 9, 2022
Mutation-related magnetization-transfer, not axon density, drives white matter differences in premanifest Huntington disease: Evidence from in vivo ultra-strong gradient MRIChiara Casella, Maxime Chamberland, Pedro L Laguna, et al.
Pilot and Feasibility Studies|February 16, 2018
Exploring computerised cognitive training as a therapeutic intervention for people with Huntington's disease (CogTrainHD): protocol for a randomised feasibility studyEmma Yhnell, Hannah Furby, Rachel S Breen, et al.
Brain : a Journal of Neurology|April 12, 2003
Progressive striatal and cortical dopamine receptor dysfunction in Huntington's disease: a PET studyNicola Pavese, Thomasin C Andrews, David J Brooks, et al.
Pilot and Feasibility Studies|June 25, 2020
A randomised feasibility study of computerised cognitive training as a therapeutic intervention for people with Huntington's disease (CogTrainHD)Emma Yhnell, Hannah Furby, Rachel S Lowe, et al.
Scientific Reports|September 2, 2016
Longitudinal in vivo MRI in a Huntington's disease mouse model: Global atrophy in the absence of white matter microstructural damageJessica J Steventon, Rebecca C Trueman, Da Ma, et al.
Neurology|March 26, 2021
Timing and Impact of Psychiatric, Cognitive, and Motor Abnormalities in Huntington DiseaseBranduff McAllister, James F Gusella, G Bernhard Landwehrmeyer, et al.
Cytotherapy|November 28, 2020
Induced pluripotent stem cells derived from the developing striatum as a potential donor source for cell replacement therapy for Huntington diseaseNarawadee Choompoo, Oliver J M Bartley, Sophie V Precious, et al.
Pageof 10